Clinical Trial

Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients

Study acronym: PROMISE
Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the feasibility and preliminary effects of precision tobacco treatment, compared to usual care, on promoting tobacco treatment in oncology patients and providers in the oncology care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This intervention may increase patient receipt of tobacco treatment, patient medication use, and patient smoking abstinence at 6 months.
Protocol Amendment History 1 change
notable Enrollment increased: 112 -> 132 participants 2026-07-25
Trial Details
NCT Number NCT07166120
Lead Sponsor Washington University School of Medicine
Collaborators: United States Department of Defense
Conditions Smoking Cessation, Smoking, Physician's Role
Enrollment 132 participants
Start Date 2025-09-11
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-24